UK drugmaker GSK lifts 2025 guidance despite US tariffs
GSK now expects 2025 revenue growth of six to seven percent, double the lower end of its previous…
Uncovering 3 Undiscovered Gems In The United Kingdom Market
As the United Kingdom’s FTSE 100 index faces downward pressure from weak trade data out of China, investors…
Undiscovered Gems In Europe Top Stocks To Explore This October 2025
As the pan-European STOXX Europe 600 Index inches higher, buoyed by dovish signals from the U.S. Federal Reserve…
2 Internet Stocks to Keep an Eye On and 1 We Question
Whether it be online shopping or social media, secular forces are propelling consumer internet businesses forward. These themes…
High Growth Tech Stocks To Watch In The UK October 2025
Amidst the backdrop of a faltering FTSE 100, impacted by weak trade data from China and declining commodity…
Oracle Sinks on Report Its Cloud Margins Are Lower Than Expected
The Oracle offices in Redwood City, California. (Bloomberg) — Oracle Corp. shares tumbled after a report that the…
Discovering Europe’s Undiscovered Gems This October 2025
As October 2025 unfolds, the European market is experiencing a notable upswing, with the pan-European STOXX Europe 600…
UK’s September 2025 Stocks That May Be Trading Below Estimated Value
In recent weeks, the UK stock market has faced challenges, with the FTSE 100 and FTSE 250 indices…
UK£0.052 loss per share (vs UK£0.041 loss in 1H 2024)
Revenue: UK£783.4m (down 7.6% from 1H 2024). Net loss: UK£66.1m (loss widened by 5.4% from 1H 2024). UK£0.052…
UK£0.18 loss per share (vs UK£0.67 loss in 1H 2024)
Revenue: UK£8.55b (down 31% from 1H 2024). Net loss: UK£182.0m (loss narrowed by 73% from 1H 2024). UK£0.18…